We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Federal Trade Commission Finds Impax, Endo Paid To Delay Generic Opioid Opana

Mealey's (April 2, 2019, 8:28 AM EDT) -- WASHINGTON, D.C. — The U.S. Federal Trade Commission on March 29 announced that it voted 5-0 that Impax Laboratories LLC engaged in an illegal pay-for-delay or “reverse payment” settlement with Endo...
To view the full article, register now.